NCT05060328

Brief Summary

This study investigates the use of Google Translate "Conversation Mode" translation service to improve communication about pain and nausea with Spanish-speaking patients who are recovering after surgery. The Google Translate "Conversation Mode" translation application is designed to provide translation from one language to another and used to allow the nurse or study doctor to communicate with patients in Spanish by asking pre-prepared questions through an electronic device such as an iPad or iPhone. Google Translate "Conversation Mode" may facilitate assessment of pain and nausea after surgery in Spanish speaking patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 22, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 15, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 29, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 22, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2022

Completed
Last Updated

April 4, 2022

Status Verified

March 1, 2022

Enrollment Period

9 months

First QC Date

September 15, 2021

Last Update Submit

March 22, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Ability to respond to the questions when asked using Google Translate

    The feasibility rate and its 95% confidence interval will be estimated.

    1 year

Study Arms (1)

Health services research (Google Translate Conversation Mode)

Patients use Google Translate "Conversation Mode" translation application before and after surgery. Patients also complete survey over 10 minutes.

Other: Medical Device Usage and EvaluationOther: Survey Administration

Interventions

Use Google Translate "Conversation Mode" translation application.

Health services research (Google Translate Conversation Mode)

Complete survey

Health services research (Google Translate Conversation Mode)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with scheduled surgery under general anesthesia and will require translation services as part of standard care

You may qualify if:

  • Ability to provide written informed consent
  • Patients between 18-80 years of age whose primary language is Spanish and will require translation services as part of standard care
  • American Society of Anesthesiologists physical status (ASA) 1-3
  • Are scheduled surgery under general anesthesia
  • Ability to understand and complete all study questionnaires

You may not qualify if:

  • Emergency surgery
  • ASA \>= 4
  • Patients who do not require official translation services for consent purposes
  • Patients who have chronic pain and/or are taking opioids chronically (daily intake for more than a month before surgery)
  • Patients who undergo craniotomy
  • Patients with a hearing impairment that prevents the ability to hear the recorded statements; and/or a cognitive impairment that would prevent them from completing post-op assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

Hematologic Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsHematologic DiseasesHemic and Lymphatic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 15, 2021

First Posted

September 29, 2021

Study Start

June 22, 2021

Primary Completion

March 22, 2022

Study Completion

March 22, 2022

Last Updated

April 4, 2022

Record last verified: 2022-03

Locations